Updates in Diagnosis and Managements of Polymyositis: Simple Review

Alanazi, Laila Abdullah S. and Madshush, Abdullah Mohammed A. AL and Alatawi, Omniyyah Mohammed S. and Albuhairy, Asmaa Hamed M. and Aljohani, Jomana Khalid M. and Alfahimani, Asmaa Muslim and Alotaibi, Jalawi Talal A. and Alatawi, Abrar Atallah O. and Ibrahim, Mohammed Ibrahim F. Bin and Alrofydi, Saud Mohammed S. and Altemani, Marwan Fahad H. (2021) Updates in Diagnosis and Managements of Polymyositis: Simple Review. Journal of Pharmaceutical Research International, 33 (41A). pp. 239-247. ISSN 2456-9119

[thumbnail of sciencedomain,+Alanazi3341A2021JPRI72349.pdf] Text
sciencedomain,+Alanazi3341A2021JPRI72349.pdf - Published Version

Download (198kB)

Abstract

Idiopathic inflammatory myopathies (IIMs) includes an unusual group of acute, chronic, and subacute developed diseases of skeletal muscle characterized by moderate to severe muscle weakness and inflammation.Polymyositis is generally considered to be a prototypic T cell-mediated autoimmune myopathy, while DM was traditionally associated with a humoral-driven microangiopathy, though the putative autoantibodies and their targets have yet to be identified, and there is increasing evidence implicating the type I interferon pathway in the pathogenesis of the disease. Women between the ages of 50 and 70 are the most typically affected. Proximal muscular weakness is the most common clinical symptom. Inflammatory arthritis, Raynaud's phenomenon, myocarditis, and interstitial lung disease are all examples of extramuscular involvement. In this review, we overview updates in diagnosis and managements of polymyositis.

Item Type: Article
Subjects: Open Library Press > Medical Science
Depositing User: Unnamed user with email support@openlibrarypress.com
Date Deposited: 24 Mar 2023 08:33
Last Modified: 04 Sep 2024 03:49
URI: http://info.euro-archives.com/id/eprint/841

Actions (login required)

View Item
View Item